Wellborn Gayle Furgurson 4
4 · HEALTHEQUITY, INC. · Filed Dec 16, 2025
Insider Transaction Report
Form 4
Wellborn Gayle Furgurson
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-12$50.41/sh+4,339$218,729→ 24,072 total - Sale
Common Stock
2025-12-12$98.03/sh−4,339$425,331→ 19,733 total - Exercise/Conversion
Stock Options (right to buy)
2025-12-12−4,339→ 0 totalExercise: $50.41Exp: 2028-02-01→ Common Stock (4,339 underlying)
Holdings
- 2,439
Stock Option (right to buy)
Exercise: $47.21Exp: 2027-08-01→ Common Stock (2,439 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.87 to $98.20 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.
- [F2]The option is immediately exercisable.